# COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes

> **NCT04537299** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Covid19
- SARS-CoV Infection

## Interventions

- **DRUG:** Fisetin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04537299
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-29
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-11-30
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** The DSMB and NIA determined the study should be stopped due to futility.
- **Last updated:** 2025-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04537299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04537299, "COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04537299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*